MedTrace Logo

ROUTE Registry Of the Utilisation of the Transaortic (Tao) TAVI Approach Using the Edwards Sapien XT Valve

NCT01991431 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2017-02-23

No results posted yet for this study

Summary

This is an international multi-center, prospective, observational registry with consecutive patient enrollment intended to determine outcome Parameters within 30 days after transaortic transcatheter aortic valve replacement.

Conditions

  • Aortic Stenosis

Sponsors & Collaborators

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Vinayak Bapat, MD · St. Thomas' Hospital, London, UK

  • Mauro Romano, MD · Institut Hospitalier Jacques Cartier, Massy, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2015-11-30
Completion
2016-11-30

Countries

  • Austria
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991431 on ClinicalTrials.gov